Efficacy of Rapamycin in Tuberous Sclerosis-Associated Hypopigmented Macules: Back to the Future

JAMA Dermatol. 2015 Jul;151(7):703-4. doi: 10.1001/jamadermatol.2014.4299.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antibiotics, Antineoplastic / therapeutic use*
  • Female
  • Humans
  • Hypopigmentation / drug therapy*
  • Male
  • Melanosomes / ultrastructure*
  • Sirolimus / therapeutic use*
  • Skin Neoplasms / drug therapy*
  • Tuberous Sclerosis / drug therapy*

Substances

  • Antibiotics, Antineoplastic
  • Sirolimus